Pfizer Inc (PFE.N)

PFE.N on New York Stock Exchange

28.77USD
11:32am EDT
Price Change (% chg)

$0.47 (+1.66%)
Prev Close
$28.30
Open
$28.65
Day's High
$28.86
Day's Low
$28.61
Volume
2,167,819
Avg. Vol
5,967,640
52-wk High
$32.96
52-wk Low
$27.51

PFE.N

Chart for PFE.N

About

Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. The Company manages its operations through five segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health, and Consumer Healthcare. The Company’s diversified global healthcare portfolio includes human... (more)

Overall

Beta: 0.71
Market Cap (Mil.): $179,446.41
Shares Outstanding (Mil.): 6,340.86
Dividend: 0.26
Yield (%): 3.67

Financials

  PFE.N Industry Sector
P/E (TTM): 17.85 32.88 33.65
EPS (TTM): 1.59 -- --
ROI: 6.80 18.21 17.48
ROE: 13.38 18.89 18.31
Search Stocks

U.S. court upholds patents on Pfizer's cancer drug

- A U.S. district court ruled in favor of Pfizer Inc in a patent lawsuit it filed against Mylan Inc alleging patent infringement on its cancer drug, Sutent, Pfizer said.

9:00am EDT

U.S. court upholds patents on Pfizer's cancer drug

Oct 23 - A U.S. district court ruled in favor of Pfizer Inc in a patent lawsuit it filed against Mylan Inc alleging patent infringement on its cancer drug, Sutent, Pfizer said.

8:57am EDT

UPDATE 2-Drugmakers may need indemnity for fast-tracked Ebola vaccines

* Governments or multilateral agencies may offer indemnity

7:19am EDT

FDA panel votes to keep severe warning on Pfizer anti-smoking drug

- Pfizer Inc failed to convince the U.S. Food and Drug Administration to remove a black box warning on its controversial quit-smoking drug Chantix, with an advisory panel to the agency voting against the removal on Thursday.

16 Oct 2014

UPDATE 1-FDA panel votes to keep severe warning on Pfizer anti-smoking drug

Oct 16 - Pfizer Inc failed to convince the U.S. Food and Drug Administration to remove a black box warning on its controversial quit-smoking drug Chantix, with an advisory panel to the agency voting against the removal on Thursday.

16 Oct 2014

FDA votes to keep black box warning on Pfizer anti-smoking drug

Oct 16 - Pfizer Inc failed in its attempt to remove a black box warning from its controversial quit-smoking drug, Chantix, after an advisory panel to the U.S. Food and Drug Administration voted against the removal.

16 Oct 2014

Banks could miss out on $135 million fees as Abbvie drops Shire deal

LONDON - A decision by U.S. drugmaker AbbVie to scrap its plans to buy Dublin-based Shire could mean that bankers miss out on up to $135 million in fees linked to the deal.

16 Oct 2014

Wife of convicted ex-SAC employee petitions to keep cash, home

NEW YORK, Oct 15 - A federal judge in Manhattan will soon have to weigh in on how the family of a convicted insider trader should live while the man spends nearly a decade in federal prison.

15 Oct 2014

FDA staff recommend Pfizer keep black box warning on anti-smoking drug

- Pfizer Inc's quit-smoking drug Chantix received its latest setback on Tuesday after U.S. Food and Drug Administration staff recommended that the drugmaker keep a severe warning on the treatment's label.

14 Oct 2014

UPDATE 1-FDA staff recommend Pfizer keep black box warning on anti-smoking drug

Oct 14 - Pfizer Inc's quit-smoking drug Chantix received its latest setback on Tuesday after U.S. Food and Drug Administration staff recommended that the drugmaker keep a severe warning on the treatment's label.

14 Oct 2014

Competitors

  Price Change
Johnson & Johnson (JNJ.N) $102.58 +1.36
Novartis AG (NOVN.VX) CHF85.40 +0.75
Merck & Co., Inc. (MRK.N) $56.73 +1.22
Roche Holding Ltd. (ROG.VX) CHF279.40 +1.10
Abbott Laboratories (ABT.N) $42.55 +0.96
Bayer AG (BAYGn.DE) €95.41 -2.28
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €84.77 +1.34
AstraZeneca plc (AZN.L) 4,335.35p +18.50
GlaxoSmithKline plc (GSK.L) 1,414.00p +37.00

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks